Close Menu

NEW YORK — Belgian molecular diagnostics firm OncoDNA said on Friday that it has closed a €19 million ($20.6 million) Series B financing round.

The round was led by Vesalius Biocapital III and Swisscanto Invest by Zürcher Kantonalbank. Other participants included SFPI-FPIM, CPH Bank, Inventures, Sambrinvest, Sofinim, SRIW, and undisclosed existing investors.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A tissue sample from the 1960s harbors a near-complete sample of HIV, IFLScience reports.

A new bill would reshape the US National Science Foundation to include a focus on technological development, according to Science.

The Food and Drug Administration's decision to halt a SARS-CoV-2 study has drawn criticism, according to Stat News.

In Genome Biology this week: features affecting gut microbiome and parasite patterns, cellular interactions in lung tumor microenvironment, and more.

Jun
04
Sponsored by
Ovation

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.